| CAT No: | CL-RIP-01 |
| CAS No: | 1442472-39-0 |
| Mol.F: | C24H21BrFN5O2 |
| Mol.Wt.: | 510.4 |
| Chemical Name: | 1-(4-Bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
| Inventory Status: | Custom synthesis |
This impurity is related to Ripretinib is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Ripretinib is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:1-(4-Bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Ripretinib Molecular Formula: C24H21BrFN5O2
Molecular Weight: 510.4
Storage: Store in a cool, dry place.
| Product Name: | Ripretinib |
| CAS No: | 1442472-39-0 |
| Mol.F.: | C24H21BrFN5O2 |
| Mol.Wt.: | 510.4 |
Cat. No: CL-RIP-NO-01
CAS No: NA
Mol. F: C24H20BrFN6O3
Mol. Wt: 539.36
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-NO-02
CAS No: NA
Mol. F: C8H8ClN3O2
Mol. Wt: 213.6
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-NO-03
CAS No: NA
Mol. F: C17H15BrFN5O2
Mol. Wt: 420.2
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-02
CAS No: 1442470-53-2
Mol. F: C17H16BrFN4O
Mol. Wt: 391.2
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-03
CAS No: 102-07-8
Mol. F: C13H12N2O
Mol. Wt: 212.3
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-04
CAS No: NA
Mol. F: C25H23BrFN5O2
Mol. Wt: 524.4
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-05
CAS No: 2657703-87-0
Mol. F: C31H26BrFN6O3
Mol. Wt: 629.5
Inv. Status: Custom Synthesis
Cat. No: CL-RIP-06
CAS No: NA
Mol. F: C16H12BrClFN3O2
Mol. Wt: 412.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: